Skip to main content
. 2016 Oct 28;11(12):2123–2131. doi: 10.2215/CJN.05170516

Figure 5.

Figure 5.

Differing renal outcomes associated with AKI electronic alerts for clinical location of AKI subsets. (A) Renal outcome of patients with AKI divided according to place of identification of AKI. Of the patients for whom 90-day follow-up data were available, 1841 (1047, hospital-acquired AKI [HA-AKI]; 794, community-acquired AKI [CA-AKI]) had died within the 90-day follow-up period and were excluded from analysis. (B) Renal outcome of patients with CA-AKI divided according to place of identification of AKI. Of the patients for whom 90-day follow-up data were available, 794 (121, primary care–acquired AKI [PC-AKI]; 673, nonprimary care–acquired AKI [non–PC-AKI]) had died within the 90-day follow-up period and were excluded from analysis. Nonrecovery is expressed as a percentage of the whole cohort and was defined as achievement of a serum creatinine (SCr) value closest to and within 90 days still consistent with the definition of AKI in comparisons to baseline SCr values. (C) Renal outcome of patients with CA-AKI divided according to hospitalization. Of the patients for whom 90-day follow-up data were available, 794 (599, hospitalized community–acquired AKI [Hosp. CA-AKI]; 195, nonhospitalized community–acquired AKI [Non-hosp. CA-AKI]) had died within the 90-day follow-up period and were excluded from analysis.